SCHEMBL17460280

SCHEMBL17460280

Cc1ccc(Oc2c(F)cc(COc3cc4n(c(=O)n3)CC(C)(C)N4)cc2C#N)cn1

nearest known ligand 0.38

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
PLA2G7 Q13093 18/20 0.38
CHRM4 P08173 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17460328 0.92 PLA2G7 (0.44) PLA2G7
SCHEMBL17460307 0.89 PLA2G7 (0.38) PLA2G7
SCHEMBL17467719 0.85 PLA2G7 (0.39) PLA2G7CHRM4
SCHEMBL17467716 0.85 PLA2G7 (0.39) PLA2G7CHRM4
SCHEMBL17460286 0.85 PLA2G7 (0.41) PLA2G7
SCHEMBL15901429 0.84 PLA2G7 (0.43) PLA2G7
SCHEMBL15901039 0.83 PLA2G7 (0.46) PLA2G7
SCHEMBL17467737 0.82 PLA2G7 (0.44) PLA2G7
SCHEMBL15900771 0.82 PLA2G7 (0.46) PLA2G7
SCHEMBL19132522 0.82 PLA2G7 (0.42) PLA2G7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016012916-A1 1,2,3,5-TETRAHYDROIMIDAZO[1,2-C]PYRIMIDINE DERIVATIVES USEFUL IN THE TREATMENT OF DISEASES AND DISORDERS MEDIATED BY LP-PLA2 GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) 2016-01-28 WO disclosed
WO-2016012916-A1 1,2,3,5-TETRAHYDROIMIDAZO[1,2-C]PYRIMIDINE DERIVATIVES USEFUL IN THE TREATMENT OF DISEASES AND DISORDERS MEDIATED BY LP-PLA2 GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) 2016-01-28 WO disclosed